Hanover - Delayed Quote EUR

Jazz Pharmaceuticals PLC (J7Z.HA)

Compare
91.02
+0.96
+(1.07%)
At close: April 17 at 5:25:16 PM GMT+2
Loading Chart for J7Z.HA
  • Previous Close 90.06
  • Open 89.08
  • Bid 90.30 x --
  • Ask 90.52 x --
  • Day's Range 89.08 - 91.02
  • 52 Week Range 86.98 - 139.90
  • Volume 0
  • Avg. Volume 3
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: J7Z.HA

View More

Performance Overview: J7Z.HA

Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

J7Z.HA
22.63%
S&P 500 (^GSPC)
12.60%

1-Year Return

J7Z.HA
9.88%
S&P 500 (^GSPC)
3.49%

3-Year Return

J7Z.HA
41.32%
S&P 500 (^GSPC)
17.00%

5-Year Return

J7Z.HA
16.26%
S&P 500 (^GSPC)
87.85%

Compare To: J7Z.HA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: J7Z.HA

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    5.48B

  • Enterprise Value

    8.26B

  • Trailing P/E

    11.99

  • Forward P/E

    4.48

  • PEG Ratio (5yr expected)

    0.32

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    1.54

  • Enterprise Value/Revenue

    2.31

  • Enterprise Value/EBITDA

    6.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: J7Z.HA

View More

Company Insights: J7Z.HA

Research Reports: J7Z.HA

View More